|
2018-09-04 |
2018-08-30 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
82.304
-55.6%
27,40
2.255.492 USD
|
82.304
-55.6%
|
27,40
|
2.255.492 USD
|
|
|
2018-08-17 |
2018-08-16 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
1.480
-2.2%
20,08
29.715 USD
|
1.480
-2.2%
|
20,08
|
29.715 USD
|
|
|
2018-08-17 |
2018-08-16 |
GV
Geplanter Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
Führungsperson
|
695
-3.0%
20,19
14.035 USD
|
695
-3.0%
|
20,19
|
14.035 USD
|
|
|
2018-07-06 |
2018-07-03 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
867
-1.3%
22,47
19.482 USD
|
867
-1.3%
|
22,47
|
19.482 USD
|
|
|
2018-06-08 |
2018-06-08 |
GV
Geplanter Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
|
455
-2.2%
22,81
10.378 USD
|
455
-2.2%
|
22,81
|
10.378 USD
|
|
|
2017-08-24 |
2017-08-23 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
1.332
-0.7%
23,30
31.036 USD
|
1.332
-0.7%
|
23,30
|
31.036 USD
|
|
|
2017-08-16 |
2017-08-15 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
1.090
-0.5%
24,08
26.247 USD
|
1.090
-0.5%
|
24,08
|
26.247 USD
|
|
|
2017-08-16 |
2017-08-15 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
|
2.350
-4.1%
24,08
56.588 USD
|
2.350
-4.1%
|
24,08
|
56.588 USD
|
|
|
2017-08-16 |
2017-08-15 |
GV
Geplanter Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
|
770
-4.5%
24,09
18.549 USD
|
770
-4.5%
|
24,09
|
18.549 USD
|
|
|
2017-08-15 |
2017-08-11 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
|
39.357
-40.6%
23,37
919.631 USD
|
39.357
-40.6%
|
23,37
|
919.631 USD
|
|
|
2017-07-05 |
2017-07-01 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
956
-1.6%
24,33
23.259 USD
|
956
-1.6%
|
24,33
|
23.259 USD
|
|
|
2017-06-16 |
2017-06-16 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
|
13.787
-19.1%
22,73
313.379 USD
|
13.787
-19.1%
|
22,73
|
313.379 USD
|
|
|
2017-06-16 |
2017-06-15 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
|
29.160
-33.4%
22,83
665.723 USD
|
29.160
-33.4%
|
22,83
|
665.723 USD
|
|
|
2017-05-30 |
2017-05-25 |
V
Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
50.000
-20.1%
22,70
1.135.000 USD
|
50.000
-20.1%
|
22,70
|
1.135.000 USD
|
|
|
2017-05-15 |
2017-05-12 |
V
Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
Führungsperson
|
800
-6.0%
21,77
17.419 USD
|
800
-6.0%
|
21,77
|
17.419 USD
|
|
|
2017-05-15 |
2017-05-12 |
V
Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
Führungsperson
|
200
-1.5%
21,77
4.354 USD
|
200
-1.5%
|
21,77
|
4.354 USD
|
|
|
2017-05-10 |
2017-05-10 |
V
Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
Führungsperson
|
902
-6.3%
21,61
19.492 USD
|
902
-6.3%
|
21,61
|
19.492 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
3.926.068
-42.2%
20,23
79.424.356 USD
|
3.926.068
-42.2%
|
20,23
|
79.424.356 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
57.488
-42.2%
20,23
1.162.982 USD
|
57.488
-42.2%
|
20,23
|
1.162.982 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Verkauf
|
WCAS MANAGEMENT CORP
Large shareholder
|
3.214
-42.2%
20,23
65.019 USD
|
3.214
-42.2%
|
20,23
|
65.019 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
3.926.068
-42.2%
20,23
79.424.356 USD
|
3.926.068
-42.2%
|
20,23
|
79.424.356 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
57.488
-42.2%
20,23
1.162.982 USD
|
57.488
-42.2%
|
20,23
|
1.162.982 USD
|
|
|
2017-01-24 |
2017-01-23 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
561
-0.2%
21,79
12.225 USD
|
561
-0.2%
|
21,79
|
12.225 USD
|
|
|
2017-01-24 |
2017-01-20 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
27.965
-10.1%
21,61
604.324 USD
|
27.965
-10.1%
|
21,61
|
604.324 USD
|
|
|
2017-01-19 |
2017-01-19 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
27.969
-10.1%
21,39
598.257 USD
|
27.969
-10.1%
|
21,39
|
598.257 USD
|
|
|
2017-01-19 |
2017-01-18 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
24.329
-8.9%
21,58
525.010 USD
|
24.329
-8.9%
|
21,58
|
525.010 USD
|
|
|
2017-01-19 |
2017-01-17 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
20.000
-7.4%
21,85
436.996 USD
|
20.000
-7.4%
|
21,85
|
436.996 USD
|
|
|
2016-11-18 |
2016-11-16 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
64.674
-32.2%
18,39
1.189.355 USD
|
64.674
-32.2%
|
18,39
|
1.189.355 USD
|
|
|
2016-11-18 |
2016-11-16 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
64.674
-32.2%
18,39
1.189.355 USD
|
64.674
-32.2%
|
18,39
|
1.189.355 USD
|
|
|
2016-11-18 |
2016-11-16 |
V
Verkauf
|
WCAS MANAGEMENT CORP
Large shareholder
|
3.616
-32.2%
18,39
66.498 USD
|
3.616
-32.2%
|
18,39
|
66.498 USD
|
|
|
2016-11-18 |
2016-11-16 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
4.416.825
-32.2%
18,39
81.225.412 USD
|
4.416.825
-32.2%
|
18,39
|
81.225.412 USD
|
|
|
2016-11-18 |
2016-11-16 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
4.416.825
-32.2%
18,39
81.225.412 USD
|
4.416.825
-32.2%
|
18,39
|
81.225.412 USD
|
|
|
2016-07-06 |
2016-07-01 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
943
-2.3%
15,70
14.807 USD
|
943
-2.3%
|
15,70
|
14.807 USD
|
|
|
2016-05-24 |
2016-05-21 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
6.465
-19.5%
11,32
73.184 USD
|
6.465
-19.5%
|
11,32
|
73.184 USD
|
|
|
2016-05-10 |
2016-05-07 |
V
Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
1.702
-11.9%
11,45
19.488 USD
|
1.702
-11.9%
|
11,45
|
19.488 USD
|
|
|
2016-05-10 |
2016-05-07 |
V
Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
Führungsperson
|
900
-17.7%
11,40
10.260 USD
|
900
-17.7%
|
11,40
|
10.260 USD
|
|
|
2016-05-05 |
2016-05-05 |
K
Kauf
|
FERRER CARLOS A
Nicht geschäftsführender Verwaltungsratsmitglied
|
20.000
+50.8%
11,32
226.400 USD
|
20.000
+50.8%
|
11,32
|
226.400 USD
|
|
|
2016-03-07 |
2016-03-07 |
K
Kauf
|
FERRER CARLOS A
Nicht geschäftsführender Verwaltungsratsmitglied
|
38.942
+8850.5%
12,84
500.015 USD
|
38.942
+8850.5%
|
12,84
|
500.015 USD
|
|
|
2015-11-13 |
2015-11-12 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
20.245
-69.0%
19,31
390.931 USD
|
20.245
-69.0%
|
19,31
|
390.931 USD
|
|
|
2015-11-13 |
2015-11-11 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
21.329
-70.1%
20,07
428.073 USD
|
21.329
-70.1%
|
20,07
|
428.073 USD
|
|
|
2015-08-11 |
2015-08-07 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
1.200
-11.7%
21,76
26.112 USD
|
1.200
-11.7%
|
21,76
|
26.112 USD
|
|
|
2015-08-11 |
2015-08-07 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
40.374
-79.7%
20,99
847.450 USD
|
40.374
-79.7%
|
20,99
|
847.450 USD
|
|
|
2015-07-21 |
2015-07-17 |
V
Verkauf
|
FERRER CARLOS A
Nicht geschäftsführender Verwaltungsratsmitglied
|
3.042
-5.0%
22,37
68.050 USD
|
3.042
-5.0%
|
22,37
|
68.050 USD
|
|
|
2015-07-21 |
2015-07-17 |
V
Verkauf
|
FERRER CARLOS A
Nicht geschäftsführender Verwaltungsratsmitglied
|
83.365
-5.0%
22,37
1.864.875 USD
|
83.365
-5.0%
|
22,37
|
1.864.875 USD
|
|
|
2015-07-17 |
2015-07-17 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
467.293
-3.3%
22,60
10.560.822 USD
|
467.293
-3.3%
|
22,60
|
10.560.822 USD
|
|
|
2015-07-17 |
2015-07-17 |
V
Verkauf
|
WCAS MANAGEMENT CORP
Large shareholder
|
383
-3.3%
22,60
8.656 USD
|
383
-3.3%
|
22,60
|
8.656 USD
|
|
|
2015-07-17 |
2015-07-17 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
6.842
-3.3%
22,60
154.629 USD
|
6.842
-3.3%
|
22,60
|
154.629 USD
|
|
|
2015-07-17 |
2015-07-17 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
6.842
-3.3%
22,60
154.629 USD
|
6.842
-3.3%
|
22,60
|
154.629 USD
|
|
|
2015-07-17 |
2015-07-17 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
467.293
-3.3%
22,60
10.560.822 USD
|
467.293
-3.3%
|
22,60
|
10.560.822 USD
|
|
|
2015-07-15 |
2015-07-13 |
V
Verkauf
|
FERRER CARLOS A
Nicht geschäftsführender Verwaltungsratsmitglied
|
20.279
-25.0%
22,37
453.641 USD
|
20.279
-25.0%
|
22,37
|
453.641 USD
|
|
|
2015-07-15 |
2015-07-13 |
V
Verkauf
|
FERRER CARLOS A
Nicht geschäftsführender Verwaltungsratsmitglied
|
555.769
-25.0%
22,37
12.432.553 USD
|
555.769
-25.0%
|
22,37
|
12.432.553 USD
|
|
|
2015-07-13 |
2015-07-13 |
V
Verkauf
|
WCAS MANAGEMENT CORP
Large shareholder
|
2.551
-18.0%
22,60
57.653 USD
|
2.551
-18.0%
|
22,60
|
57.653 USD
|
|
|
2015-07-13 |
2015-07-13 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
45.616
-18.0%
22,60
1.030.922 USD
|
45.616
-18.0%
|
22,60
|
1.030.922 USD
|
|
|
2015-07-13 |
2015-07-13 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
3.115.287
-18.0%
22,60
70.405.486 USD
|
3.115.287
-18.0%
|
22,60
|
70.405.486 USD
|
|
|
2015-07-13 |
2015-07-13 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
45.616
-18.0%
22,60
1.030.922 USD
|
45.616
-18.0%
|
22,60
|
1.030.922 USD
|
|
|
2015-07-13 |
2015-07-13 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
3.115.287
-18.0%
22,60
70.405.486 USD
|
3.115.287
-18.0%
|
22,60
|
70.405.486 USD
|
|
|
2015-06-29 |
2015-06-29 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
8.848
-96.6%
24,05
212.794 USD
|
8.848
-96.6%
|
24,05
|
212.794 USD
|
|
|
2015-06-29 |
2015-06-26 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
15.300
-98.0%
24,01
367.353 USD
|
15.300
-98.0%
|
24,01
|
367.353 USD
|
|
|
2015-06-29 |
2015-06-25 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
14.841
-98.0%
24,55
364.347 USD
|
14.841
-98.0%
|
24,55
|
364.347 USD
|
|
|
2015-06-24 |
2015-06-24 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
6.459
-2.7%
24,27
156.760 USD
|
6.459
-2.7%
|
24,27
|
156.760 USD
|
|
|
2015-06-24 |
2015-06-24 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
8.034
-96.3%
24,27
194.985 USD
|
8.034
-96.3%
|
24,27
|
194.985 USD
|
|
|
2015-06-24 |
2015-06-23 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
10.668
-4.3%
24,89
265.527 USD
|
10.668
-4.3%
|
24,89
|
265.527 USD
|
|
|
2015-06-24 |
2015-06-23 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
10.711
-97.2%
24,91
266.811 USD
|
10.711
-97.2%
|
24,91
|
266.811 USD
|
|
|
2015-06-24 |
2015-06-22 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
7.210
-3.0%
25,36
182.846 USD
|
7.210
-3.0%
|
25,36
|
182.846 USD
|
|
|
2015-06-24 |
2015-06-22 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
8.639
-96.6%
25,36
219.085 USD
|
8.639
-96.6%
|
25,36
|
219.085 USD
|
|
|
2015-06-23 |
2015-06-19 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
18.165
-7.1%
24,94
453.035 USD
|
18.165
-7.1%
|
24,94
|
453.035 USD
|
|
|
2015-06-18 |
2015-06-18 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
24.900
-11.6%
24,80
617.520 USD
|
24.900
-11.6%
|
24,80
|
617.520 USD
|
|
|
2015-06-18 |
2015-06-17 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
10.109
-4.5%
24,28
245.447 USD
|
10.109
-4.5%
|
24,28
|
245.447 USD
|
|
|
2015-06-05 |
2015-06-03 |
V
Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
13.350
-97.7%
24,57
328.010 USD
|
13.350
-97.7%
|
24,57
|
328.010 USD
|
|
|
2015-02-13 |
2015-02-12 |
V
Verkauf
|
BRODNAX BRETT
Nicht geschäftsführender Verwaltungsratsmitglied
|
5.564
-17.1%
19,73
109.778 USD
|
5.564
-17.1%
|
19,73
|
109.778 USD
|
|
|
2015-02-10 |
2015-02-09 |
V
Verkauf
|
WCAS MANAGEMENT CORP
Large shareholder
|
728
-4.9%
18,75
13.650 USD
|
728
-4.9%
|
18,75
|
13.650 USD
|
|
|
2015-02-10 |
2015-02-09 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
13.031
-4.9%
18,75
244.331 USD
|
13.031
-4.9%
|
18,75
|
244.331 USD
|
|
|
2015-02-10 |
2015-02-09 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
889.990
-4.9%
18,75
16.687.313 USD
|
889.990
-4.9%
|
18,75
|
16.687.313 USD
|
|
|
2015-02-10 |
2015-02-09 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
889.990
-4.9%
18,75
16.687.313 USD
|
889.990
-4.9%
|
18,75
|
16.687.313 USD
|
|
|
2015-02-10 |
2015-02-09 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
13.031
-4.9%
18,75
244.331 USD
|
13.031
-4.9%
|
18,75
|
244.331 USD
|
|
